X ZELL is a global pioneer in multiplexed immunostaining – a patented technology set to revolutionize cancer diagnostics by applying multiple diagnostic antibodies simultaneously to a single specimen.
Our FDA and CE IVD registered next generation cytology platform was specifically designed for minimally invasive cytology samples and processes up to eight antibodies at once – maximizing diagnostic yield while cutting turnaround by over 90%. No complex preparation. No sample wastage.
By combining multiplexing with cutting edge digital imaging, we help laboratories deliver faster, more patient friendly, and personalized care – ready for the digital age.
In May 2025, we previewed our new Cryophore™ range, the world’s first standardized, expert vetted multiplexing panels for routine cytopathology, set to launch globally in Q4 2025.
Headquartered in Singapore, X ZELL operates regional offices in Germany, Thailand, and the US to advance diagnostics and improve patient care worldwide.
Company Details
- Employees
- 20
- Founded
- 2014
- Address
- 133 Cecil St, Keck Seng Tower, #06-02,united States
- Phone
- +66 2 087 8499
- in****@****ell.com
- Industry
- Biotechnology
- Website
- x-zell.com
- Keywords
- Biotechnology, Cancer Detection, Liquid Biopsy, Medical Device Development, Immunostaining, Health Technology, Med Tech, Digital Health, AI, Cryobiology, Single Cell Diagnostics, Screening.
- HQ
- Singapore, Singapore
X-Zell Questions
X-Zell's helpline number is +66 2 087 8499
X-Zell's website is x-zell.com
X-Zell's LinkedIn profile is https://www.linkedin.com/company/xzell
X-Zell has
20 employees.
View email and phone details for 20
employees at X-Zell.
X-Zell's industry is
Biotechnology
X-Zell's top competitors are
Teamnote Limited,
Uwi,
Pivot (Yc S22),
Tiny (Yc F24),
Flagright,
Fireroad,
Quidli,
Mymotion.de Gmbh & Co. Kg,
Zapi,
Flintec Singapore Pte Ltd.
X-Zell's support email address is info@x-zell.com
X-Zell's categories are Biotechnology
X-Zell's founding year is 2014
